Peter G. Pappas

Peter Pappas practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Peter Pappas' NPI, 1811921497, was assigned on July 10, 2006. Peter Pappas graduated from University of Alabama School of Medicine in 1993. Peter Pappas holds Alabama license 14318.

Peter Pappas' primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Peter Pappas' primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Peter Pappas is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Peter Pappas practices. Vendor and product names are available with a free account.

Infectious disease is Peter Pappas' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Peter Pappas is licensed in Alabama.

CMS data shows 96 Medicare services from Peter Pappas across 4 procedure codes in 2024, for 53 Medicare patients. Medicare paid $5,073 for them.

CMS counts 53 Medicare patients who saw Peter Pappas in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 3.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Peter Pappas' median patient age at 61, with 43% women.

In 2024, Peter Pappas wrote 233 Medicare Part D claims for 36 patients. 89% of them were for generic drugs. CMS names the drug for 153 of them, across 9 drugs with 11 or more claims each, at $21,760 in total drug cost. In 2023, CMS named 178 claims across 10 drugs.

Peter Pappas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Peter Pappas as offering telehealth.

Dmand AI links 142 papers to Peter Pappas, published from 2003 to 2025. 2024 was the busiest year, with 15. The most frequent topics are Antifungal Agents, Candida and Candidemia. Peter Pappas has published most often in Clin Infect Dis. Peter Pappas' most frequent co-authors are John W. Baddley, MD, Todd Patrick McCarty and John Robert Perfect, MD.

Dmand AI links Peter Pappas to 5 clinical trials. Conditions studied include Blastomycosis, Mycoses and Aspergillosis. University of Alabama at Birmingham sponsors the most, 2. Open Payments lists research payments to Peter Pappas that name 1 trial.

CMS Open Payments shows 53 general payments to Peter Pappas from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Gilead Sciences, Inc. paid the most, $33,427. It also lists 20 research payments totaling $19,105 from 2016 to 2023, naming 1 clinical trial.

Peter Pappas graduated from University of Alabama School of Medicine in 1993.